UK markets closed

RAPT Therapeutics, Inc. (RAPT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.0400-0.1000 (-2.42%)
At close: 04:00PM EDT
4.0400 0.00 (0.00%)
After hours: 05:53PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
47,478
38,946
24,027
24,918
Other short-term investments
111,384
210,122
165,627
86,592
Total cash
158,862
249,068
189,654
111,510
Other current assets
2,920
3,626
3,319
4,088
Total current assets
161,782
252,694
192,973
115,598
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
17,043
17,728
10,425
10,064
Accumulated depreciation
-9,367
-8,249
-7,684
-7,082
Net property, plant and equipment
7,676
9,479
2,741
2,982
Other long-term assets
3,871
4,036
2,922
389
Total non-current assets
11,547
13,515
5,663
3,371
Total assets
173,329
266,209
198,636
118,969
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
5,176
3,365
1,999
2,383
Accrued liabilities
7,800
4,038
2,674
1,968
Deferred revenues
-
0
1,016
4,096
Other current liabilities
109
32
254
328
Total current liabilities
21,836
14,224
9,595
11,742
Non-current liabilities
Deferred revenues
-
0
511
863
Total non-current liabilities
4,458
6,819
2,661
3,048
Total liabilities
26,294
21,043
12,256
14,790
Stockholders' equity
Common stock
3
3
3
2
Retained earnings
-484,682
-367,884
-284,046
-214,842
Accumulated other comprehensive income
103
-26
-206
-177
Total stockholders' equity
147,035
245,166
186,380
104,179
Total liabilities and stockholders' equity
173,329
266,209
198,636
118,969